搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Too Old to Operate
3 天
Patency Rates After OSR and FB-EVAR for Target Artery Reconstruction
The following is a summary of “Target Artery Outcomes Following Endovascular versus Open Surgical Repair of Thoracoabdominal ...
Medscape
1 个月
Extensive Unilateral Iliofemoral Occlusions: Durability of Four Techniques of Arterial ...
Comparative Patency Rates: Review of Literature of Past 10 Years ...
TCTMD
1 个月
TCT 294: Graft Patency After Quantitative Flow Ratio-Guided Coronary Artery Bypass Grafting ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
9 天
Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and ...
In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection resistance ...
Endovascular Today
10 天
Solaris Endovascular, Inc. Launched in the United States
Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...
9 天
Humacyte announces publication of results on ATEV
Humacyte (HUMA) announced the publication of clinical results evaluating the efficacy and safety of the acellular tissue engineered vessel, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈